Non disponible en dehors du Royaume-Uni et de l'Irlande
Biochem/physiol Actions
Suitable for the determination of uric acid in clinical analysis.
General description
Uricase deficient mice develop uric acid nephropathy and diabetes insipidus which can be mitigated with recombinant uricase treatment.
Packaging
250, 1000 units in glass bottle
Physical form
Powder; contains citrate and sucrose
Unit Definition
One unit will oxidize 1.0 µmole of uric acid to allantoin per minute at pH 8.5 at 25 °C.
Ce produit répond aux critères suivants: